V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190006136 | 190001316 | null | null | null | null | 2017-01-03 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100067481 |
| 190006137 | 190001317 | 1.6 | 12.5 | Palliative (P) | 2018-07-06 | 2018-07-06 | EW EuroEwing 2012 Arm B VDC | 02 | N | CAPECITABINE + OXALIPLATIN | 101034738 |
| 190006144 | 190001320 | 1.68 | 85.7 | Curative (C) | 2019-02-09 | 2019-02-11 | Carboplatin + Etoposide IV 3 day | 02 | Y | CARBOPLATIN + ETOPOSIDE | 100600698 |
| 190006145 | 190001321 | 0 | 49.3 | Curative (C) | 2019-11-15 | 2019-11-23 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 100434082 |
| 190006157 | 190001326 | 1.66 | 62.4 | Palliative (P) | 2017-06-09 | 2017-07-05 | VIDE | null | Y | CAPECITABINE | 100128733 |
| 190006158 | 190001327 | null | null | null | null | 2020-04-02 | Trial Unspecified | null | null | CETUXIMAB | 101362232 |
| 190006161 | 190001329 | null | null | null | 2016-12-08 | 2016-12-08 | PAM x 2 pre-surgery (cycles 1&2) | N | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100058877 |
| 190006164 | 190001331 | 1.61 | 78 | Curative (C) | 2019-12-23 | 2020-01-02 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101150050 |
| 190006165 | 190001332 | null | null | null | null | 2019-11-24 | CAPECITABINE + OXALIPLATIN | null | null | EOX | 100911215 |
| 190006168 | 190001333 | 1.53 | 83.6 | Palliative (P) | 2016-12-26 | 2016-12-27 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | CISPLATIN + ETOPOSIDE | 101831109 |
| 190006171 | 190001335 | 1.78 | 79 | Palliative (P) | 2017-10-03 | 2017-10-04 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100699473 |
| 190006172 | 190001336 | 1.78 | 82.6 | Neo-adjuvant (N) | 2019-12-30 | 2020-01-02 | EW EuroEwing 99 : VIDE | 02 | N | FLUOROURACIL + OXALIPLATIN | 100040410 |
| 190006173 | 190001337 | 1.78 | 76.6 | Curative (C) | 2016-04-23 | 2016-04-26 | CHOP R | 02 | null | CISPLATIN + ETOPOSIDE | 101453935 |
| 190006177 | 190001339 | 1.6 | 48 | Neo-adjuvant (N) | 2019-07-31 | 2019-08-08 | Cisplatin + Radiotherapy | Y | N | CISPLATIN | 100666746 |
| 190006178 | 190001340 | 1.64 | 72 | Palliative (P) | 2016-07-16 | 2016-08-09 | Doxorubicin 75mg/m2 | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101148801 |
| 190006184 | 190001342 | null | null | null | null | 2020-09-23 | Cisplatin 100 + RT(H&N) 1 day | null | null | CISPLATIN | 101753332 |
| 190006191 | 190001345 | null | null | null | null | 2018-02-14 | EW Rel rEECur Irinotecan/Temozolomide | null | null | CAPECITABINE + CARBOPLATIN | 101589121 |
| 190006193 | 190001346 | null | null | null | null | 2020-01-20 | Capecitabine (21days) + Carboplatin | null | null | CARBOPLATIN + DOXORUBICIN | 100431121 |
| 190006201 | 190001350 | null | null | null | null | 2017-09-12 | Cisplatin | null | null | CISPLATIN | 100706357 |
| 190006207 | 190001351 | null | null | null | null | 2017-08-08 | EURAMOS TRIAL | null | null | CAV | 101849036 |
| 190006212 | 190001354 | 0 | 81.6 | null | 2020-10-20 | 2020-10-22 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100790741 |
| 190006213 | 190001355 | 1.61 | 48.6 | null | 2018-07-11 | 2018-07-11 | Cisplatin + Radiotherapy | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100314417 |
| 190006214 | 190001356 | null | null | null | null | 2018-05-06 | Cisplatin 7 day | null | null | CISPLATIN | 101009635 |
| 190006222 | 190001360 | null | null | null | null | 2017-07-15 | Bortezomib + CYCLOPHOSPHAMIDE | null | null | DOXORUBICIN + OLARATUMAB | 101643703 |
| 190006225 | 190001361 | 0 | 0 | Curative (C) | 2016-06-12 | 2016-07-03 | Cisplatin + Radiotherapy + CISPLATIN | 02 | Y | CISPLATIN | 100324283 |
| 190006230 | 190001363 | 1.8 | 50.4 | Curative (C) | 2016-05-24 | 2016-06-05 | GC Int Guide Excranial GermCell JEB | N | N | DOCETAXEL + GEMCITABINE | 100644422 |
| 190006231 | 190001364 | null | null | null | null | 2016-11-06 | Dox + HD Mtx (post PAM) | null | null | CAPECITABINE + OXALIPLATIN | 101082086 |
| 190006238 | 190001365 | null | 59.8 | Neo-adjuvant (N) | 2016-03-09 | 2016-03-14 | Hydroxycarbamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101345207 |
| 190006240 | 190001367 | 1.76 | null | Palliative (P) | 2020-03-08 | 2020-03-11 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101365131 |
| 190006244 | 190001368 | 1.67 | 62.5 | Curative (C) | 2017-04-10 | 2017-04-10 | Doxorubicin 75mg/m2 | null | N | CARBOPLATIN | 101719780 |
| 190006245 | 190001369 | 1.83 | 42.5 | Disease modification (D) | 2018-02-02 | 2018-02-17 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100811659 |
| 190006248 | 190001370 | null | null | null | null | 2019-12-05 | EW EuroEwing 2012 Arm A VIDE | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100859863 |
| 190006251 | 190001372 | 1.6 | 60.5 | Palliative (P) | 2018-08-11 | 2018-08-14 | FLUOROURACIL + OXALIPLATIN | 2 | null | FLUOROURACIL + OXALIPLATIN | 100497738 |
| 190006253 | 190001373 | null | null | null | null | 2019-10-30 | EW EuroEwing 2012 Arm A VIDE | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100904595 |
| 190006257 | 190001375 | null | null | null | null | 2019-12-26 | Cisplatin | null | null | CISPLATIN | 101187652 |
| 190006261 | 190001376 | null | null | null | null | 2018-12-05 | EURAMOS TRIAL | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100470412 |
| 190006263 | 190001378 | null | null | null | null | 2019-12-13 | Cetuximab + Radiotherapy Load | null | null | DOXORUBICIN | 101683093 |
| 190006266 | 190001379 | null | null | null | null | 2017-12-05 | Dox + HD Mtx (post PAM) | null | null | TRIAL UNSPECIFIED | 101849234 |
| 190006268 | 190001381 | 1.78 | 18.9 | Palliative (P) | 2018-11-04 | 2018-11-04 | Carboplatin + Paclitaxel (weekly) | 2 | N | CARBOPLATIN + PACLITAXEL | 100037583 |
| 190006270 | 190001382 | 1.49 | 88.8 | Palliative (P) | 2018-07-01 | 2018-07-09 | DOXORUBICIN | 02 | N | IRINOTECAN + MDG | 100123039 |
| 190006271 | 190001383 | 1.57 | 65.7 | Palliative (P) | 2017-04-07 | 2017-05-01 | FEC 100 | 01 | N | CAPECITABINE + OXALIPLATIN | 100568991 |
| 190006281 | 190001386 | null | null | null | null | 2019-06-25 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100143488 |
| 190006288 | 190001388 | null | 101.2 | Neo-adjuvant (N) | 2016-09-26 | 2016-09-26 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101493650 |
| 190006291 | 190001390 | 1.91 | 57 | Neo-adjuvant (N) | 2019-09-28 | 2019-10-15 | CARBOPLATIN + PACLITAXEL | 2 | N | CARBOPLATIN + PACLITAXEL | 100929983 |
| 190006302 | 190001393 | null | null | null | null | 2017-12-19 | Bevacizumab+Carbo+Pacliaxel | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100786306 |
| 190006304 | 190001395 | 1.57 | 33 | null | 2020-01-02 | 2020-01-02 | CARBOPLATIN | 02 | null | GC INT GUIDE EXCRANIAL GERMCELL JEB | 101633246 |
| 190006309 | 190001396 | null | null | null | null | 2019-06-20 | MAP | null | null | CARBOPLATIN | 100526324 |
| 190006311 | 190001397 | null | null | null | null | 2018-12-23 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100325631 |
| 190006316 | 190001399 | 1.62 | 37.4 | Palliative (P) | 2018-08-12 | 2018-08-15 | EOX | 02 | N | EOX | 101717386 |
| 190006322 | 190001404 | 1.73 | 86.8 | Palliative (P) | 2016-03-29 | 2016-04-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100325955 |